Accuray and 5D Clinics Bring Innovative Cancer Treatment to Melbourne with CyberKnife®

Accuray Partners with 5D Clinics to Launch CyberKnife® in Melbourne

Accuray Incorporated, a leader in innovative radiation therapy solutions, has reached a significant milestone by commencing the first treatments with the CyberKnife S7™ System in Melbourne, Australia. This groundbreaking launch was made possible through a partnership with 5D Clinics and their joint venture partner, Icon Group. The collaboration aims to enhance cancer care accessibility across Australia, particularly as cancer incidence is projected to increase dramatically in the coming years.

The CyberKnife® Advantage

The CyberKnife® System is a state-of-the-art technology that provides robotic stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS). Its introduction in Melbourne marks an essential step forward in providing cutting-edge cancer treatment options closer to patients' homes. Previously, patients often had to travel long distances for similar treatments. The CyberKnife’s precision allows for effective cancer management while minimizing the number of sessions and time spent at medical facilities.

Suzanne Winter, President and CEO of Accuray, expressed pride in this partnership, noting, "We have a shared vision and commitment to advancing cancer care globally, and the opening of the center in Melbourne is a first step—and important reminder—of the power of determination in bringing that vision to life." This sentiment echoes a growing need for innovative treatment options as Australia faces an increasing battle against cancer.

Rising Cancer Rates and Patient Impact

The World Health Organization warns that new cancer cases diagnosed in Australia are expected to rise from 212,332 in 2022 to 318,285 by 2045, marking nearly a 50 percent increase. This alarming statistic emphasizes the urgency for healthcare innovations like the CyberKnife® System.

A testimonial from one of the first patients, David, a 55-year-old diagnosed with prostate cancer, highlights the positive influence of the CyberKnife® technology. He stated, "Choosing the CyberKnife System gave me such relief knowing I didn't have to face surgery or long hospital stays. It's allowed me to keep working and get on with life without the downtime of traditional procedures. The results I've seen have been really reassuring and given me confidence about the future." This reflects the profound impact that access to advanced treatment options can have on patients' lives.

Advantages of the CyberKnife® System

The CyberKnife S7™ System stands out in its ability to combine speed, precision, and the use of artificial intelligence. It is capable of tracking and automatically adapting to patient movement during treatment, thus ensuring radiation doses are precisely delivered to tumors regardless of their location in the body. Compared to conventional treatment methods, which often require 30 to 40 sessions, the CyberKnife® typically completes treatments within 1 to 5 outpatient visits.

Bruno Bosco, General Manager for 5D Clinics Australia, remarked on the importance of this partnership, stating, "The introduction of the CyberKnife® System to Melbourne means patients no longer need to travel interstate to access this advanced level of care. It provides more choice and the possibility of better patient outcomes and improved quality of life."

As they work to expand their reach, both Accuray and 5D Clinics, in collaboration with Icon Group, aim to deploy additional CyberKnife® centers across Australia’s east coast, thus ensuring more patients can benefit from this innovative approach.

Conclusion

The collaboration between Accuray and 5D Clinics encapsulates a forward-thinking strategy focused on enhancing cancer care while addressing the growing demands of patients across Australia. As the CyberKnife® System becomes more accessible, it is expected to transform cancer management and improve the quality of life for countless individuals battling cancer. The healthcare community looks forward to witnessing the positive changes this technology will bring in the fight against cancer.

For more information, visit Accuray.